{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T04:02:30Z","timestamp":1749355350352,"version":"3.41.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mcna.2024.09.007","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:50:45Z","timestamp":1730983845000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Initial Management of Neuromuscular Emergencies"],"prefix":"10.1016","volume":"109","author":[{"given":"Guillermo Eduardo","family":"Solorzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2024.09.007_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2008-1062270","article-title":"The evaluation of chronic axonal polyneuropathies","volume":"28","author":"Mauermann","year":"2008","journal-title":"Semin Neurol"},{"issue":"10280","key":"10.1016\/j.mcna.2024.09.007_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.mcna.2024.09.007_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"10045","key":"10.1016\/j.mcna.2024.09.007_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.007_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.mcna.2024.09.007_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The guillain-barr\u00e9 syndrome","volume":"326","author":"Ropper","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.007_bib7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/brain\/awac067","article-title":"COVID-19 vaccination and Guillain-Barr\u00e9 syndrome: analyses using the National Immunoglobulin Database","volume":"146","author":"Keh","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.mcna.2024.09.007_bib8","first-page":"2169","article-title":"Guillan-Barr\u00e9 syndrome in patients treated with immune checkpoint inhibitors","volume":"268","author":"Fan","year":"2021","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mcna.2024.09.007_bib9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome","volume":"35","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2024.09.007_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids","volume":"22","year":"1987","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.007_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00003246-200301000-00044","article-title":"Early predictors of mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mcna.2024.09.007_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ncl.2021.01.010","article-title":"Neuromuscular respiratory failure","volume":"39","author":"Singh","year":"2021","journal-title":"Neurol Clin"},{"issue":"6","key":"10.1016\/j.mcna.2024.09.007_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.007_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"issue":"3, neurocritical care","key":"10.1016\/j.mcna.2024.09.007_bib16","first-page":"818","article-title":"Neuromuscular emergencies","volume":"30","author":"Albin","year":"2024","journal-title":"Continuum"},{"issue":"9047","key":"10.1016\/j.mcna.2024.09.007_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.mcna.2024.09.007_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0000000000011795","article-title":"Neurologic adverse events from immune checkpoint inhibitors: a systematic review","volume":"96","author":"Marini","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.007_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.007_bib20","doi-asserted-by":"crossref","first-page":"e207863","DOI":"10.1212\/WNL.0000000000207863","article-title":"Hospitalizations and mortality from myasthenia gravis: trends from 2\u00a0US national datasets","volume":"102","author":"Habib","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2024.09.007_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2024.09.007_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00003246-199707000-00027","article-title":"Therapy of myasthenic crisis","volume":"25","author":"Berrouschot","year":"1997","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.007_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J\u00a0Neuroinflammation"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.007_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mus.20403","article-title":"Pulmonary function tests and blood gases in worsening myasthenia gravis","volume":"32","author":"Thieben","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mcna.2024.09.007_bib25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.007_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mcna.2024.09.007_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2024.09.007_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/RHU.0000000000001874","article-title":"Immune-checkpoint inhibitor-associated myositis: a distinct form of inflammatory myopathy","volume":"28","author":"Saygim","year":"2022","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.mcna.2024.09.007_bib29","first-page":"1564","article-title":"Immune-mediated myopathies","volume":"25","author":"Goyal","year":"2019","journal-title":"Continuum"},{"issue":"10","key":"10.1016\/j.mcna.2024.09.007_bib30","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and respiratory complications of necrotizing autoimmune myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.007_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotizing myopathy: a multi-Centre Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscl Disord"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.007_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: Clinico-seropathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscl Disord"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T12:13:55Z","timestamp":1749298435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712524001226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0025712524001226"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2024.09.007","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initial Management of Neuromuscular Emergencies","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2024.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}